Guaifenesin Solution
NDC Package 0121-1744-00

11-digit billing NDC: 00121174400 · Billing unit: ML · 500 ML per package

Package Information

Guaifenesin solution is follow dosage below or use as directed by a physician.do not take more than 6 doses in any 24-hour period. This formulation utilizes a solution delivery system. Marketed by Pai Holdings, Llc Dba Pai Pharma, this product is identified by NDC 0121-1744 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
0121-1744-00
Package Description
10 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1744-05)
Product Code
11-Digit Billing Format
00121174400
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
500 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Guaifenesin
Non-Proprietary Name
Guaifenesin
Substance Name
Guaifenesin
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Follow dosage below or use as directed by a physician.do not take more than 6 doses in any 24-hour period. age doseadults and children 12 years and over10 to 20 mL (2 to 4 teaspoonfuls) every 4 hours children 6 years to under 12 years5 to 10 mL (1 to 2 teaspoonfuls) every 4 hours children 2 to under 6 years of age2.5 to 5 mL (½ to 1 teaspoonful) every 4 hours children under 2 years of ageconsult a physician

Regulatory & Marketing

Labeler Name
Pai Holdings, Llc Dba Pai Pharma
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-01-2002
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0121-1744-00 identifies a specific commercial package of 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 5 ml in 1 cup, unit-dose (0121-1744-05) of Guaifenesin, a human over the counter drug labeled by Pai Holdings, Llc Dba Pai Pharma. This product is billed per "ML" milliliter and contains an estimated amount of 500 billable units per package. This solution is formulated for oral use and contains guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pai Holdings, Llc Dba Pai Pharma on September 01, 2002. The current certification is valid through December 31, 2027.

How is this Pai Holdings, Llc Dba Pai Pharma product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00121174400. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0121-1744-00
11-Digit CMS (5-4-2)
00121-1744-00

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.